HSP90B1 and breast cancer: Conversely, we evidenced that knockdown of gp96 suppressed cell viability (Figures 2D, E) and promoted cell apoptosis (Figure 2F, Figures S3C, D) in paclitaxel-treated PR-BC cells, hinting that silence of gp96 increased paclitaxel-sensitivity in PR-BC cells.